The Main protease (Mpro) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

Abstract The connection between COVID-19 and coagulopathy has been clear since the early days of SARS-CoV-2 pandemic. Although available data indicate that systemic inflammation sustains a hypercoagulant state and increases thrombotic risk, the underlying molecular mechanisms of COVID-19 associated coagulopathy remain unclear. Here we show that SARS-CoV-2 main protease (Mpro) can play a direct role in the activation of the coagulation cascade. Adding Mpro to human plasma increased clotting probability by 2.5-fold. The results of enzymatic assays and degradomics analysis indicate that Mpro triggers plasma clotting by proteolytically activating coagulation factor zymogens VII and XII at their physiological activation sites, involving Arg-Ile/Val bonds, where FVII and FXII are strategically positioned at the beginning of the extrinsic or intrinsic pathways of blood coagulation. Even though the observed cleavage sites are not compatible with the known substrate specificity of the protease, involving Gln-X bonds, the results of High Throughput Protease Screen assay unveil an extended, time-dependent, secondary specificity of Mpro for Arg-X bonds, which was further confirmed by enzymatic assays with synthetic peptide substrates containing Arg at P1 position. Overall, integrating biochemical, proteomics and structural biology experiments, we unveil a novel, additional mechanism linking SARS-CoV-2 infection to thrombotic complications in COVID-19.
Full text 16,680 characters · extracted from preprint-html · click to expand
The Main protease (Mpro) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article The Main protease (M pro ) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII Vincenzo De Filippis, Anna Pagotto, Federico Uliana, Giulia Nordio, and 9 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-4959212/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 01 Aug, 2025 Read the published version in Communications Biology → Version 1 posted You are reading this latest preprint version Abstract The connection between COVID-19 and coagulopathy has been clear since the early days of SARS-CoV-2 pandemic. Although available data indicate that systemic inflammation sustains a hypercoagulant state and increases thrombotic risk, the underlying molecular mechanisms of COVID-19 associated coagulopathy remain unclear. Here we show that SARS-CoV-2 main protease (Mpro) can play a direct role in the activation of the coagulation cascade. Adding Mpro to human plasma increased clotting probability by 2.5-fold. The results of enzymatic assays and degradomics analysis indicate that Mpro triggers plasma clotting by proteolytically activating coagulation factor zymogens VII and XII at their physiological activation sites, involving Arg-Ile/Val bonds, where FVII and FXII are strategically positioned at the beginning of the extrinsic or intrinsic pathways of blood coagulation. Even though the observed cleavage sites are not compatible with the known substrate specificity of the protease, involving Gln-X bonds, the results of High Throughput Protease Screen assay unveil an extended, time-dependent, secondary specificity of Mpro for Arg-X bonds, which was further confirmed by enzymatic assays with synthetic peptide substrates containing Arg at P1 position. Overall, integrating biochemical, proteomics and structural biology experiments, we unveil a novel, additional mechanism linking SARS-CoV-2 infection to thrombotic complications in COVID-19. Biological sciences/Biochemistry/Proteases Biological sciences/Microbiology/Virology/SARS-CoV-2 COVID-19 SARS-CoV-2 Main Protease thrombosis proteolysis proteomics Full Text Additional Declarations There is NO Competing Interest. Supplementary Files SupplementaryTable1.xlsx S1 SupplementaryTable2.xlsx S2 SupplementaryTable3.xlsx S3 SupplementaryTable4.xlsx S4 Cite Share Download PDF Status: Published Journal Publication published 01 Aug, 2025 Read the published version in Communications Biology → Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-4959212","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":372948093,"identity":"97d6cee1-c22b-4337-926a-af4166e0713e","order_by":0,"name":"Vincenzo De Filippis","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAABEUlEQVRIie2RsWrDMBCGJQTWItmrteQZFAx1+jY2Xotb8FIoGJmCMmVPh75Dx4wOHrz4DbI4i7eCsrVDobLjtB5Ud82gb7kfcR93hwCwWK4R9JMioKIHv3+BLQA6lFD8p8BtxAcF8VEpzM5UAXxIjj+UEhjH8Jru1WmXLwBO9qLlqzTEuHuiu1XqlmjdmpTKTdhL4wSAdLHQi2W3z+TmQBs/Y38sxnQDopLEwr8LW63EbxVxDlTqMKd86Qbh35/EWcFdNqd4SCtQ8n4KHBXQz51VAraRUeCQbnm5JWCvUt9SwWJrUByvWapPmS88nByLj8c8Db36qN5lnrr1ulUG5dcda8QvYfLL80wUi8VisZz5BqzKYGVH2uVBAAAAAElFTkSuQmCC","orcid":"https://orcid.org/0000-0001-9775-8894","institution":"University of Padua","correspondingAuthor":true,"prefix":"","firstName":"Vincenzo","middleName":"","lastName":"De Filippis","suffix":""},{"id":372948094,"identity":"af940fef-81ab-4785-abfd-3ed5daf2dbf2","order_by":1,"name":"Anna Pagotto","email":"","orcid":"","institution":"ETHZ","correspondingAuthor":false,"prefix":"","firstName":"Anna","middleName":"","lastName":"Pagotto","suffix":""},{"id":372948095,"identity":"0c99492f-13c3-4be7-bf59-7bd3a17eea6e","order_by":2,"name":"Federico Uliana","email":"","orcid":"https://orcid.org/0000-0002-8185-6438","institution":"JGU Mainz","correspondingAuthor":false,"prefix":"","firstName":"Federico","middleName":"","lastName":"Uliana","suffix":""},{"id":372948096,"identity":"ffdad3e2-8d27-4134-8b8b-5f406c18caed","order_by":3,"name":"Giulia Nordio","email":"","orcid":"","institution":"University of Padua","correspondingAuthor":false,"prefix":"","firstName":"Giulia","middleName":"","lastName":"Nordio","suffix":""},{"id":372948097,"identity":"52efd8fa-6073-43bc-9ad5-91f046b6f7c3","order_by":4,"name":"Andrea Pierangelini","email":"","orcid":"https://orcid.org/0009-0009-9396-619X","institution":"University of Padua","correspondingAuthor":false,"prefix":"","firstName":"Andrea","middleName":"","lastName":"Pierangelini","suffix":""},{"id":372948098,"identity":"0cfa23e8-6552-4b10-8323-e6db6f15da97","order_by":5,"name":"Laura Acquasaliente","email":"","orcid":"https://orcid.org/0000-0001-6495-0871","institution":"Università degli Studi di Padova","correspondingAuthor":false,"prefix":"","firstName":"Laura","middleName":"","lastName":"Acquasaliente","suffix":""},{"id":372948099,"identity":"2bf85a9e-8442-4ae1-855e-c6aa08caa3d6","order_by":6,"name":"Maria Ludovica Macchia","email":"","orcid":"https://orcid.org/0009-0001-8986-5718","institution":"University of Padua","correspondingAuthor":false,"prefix":"","firstName":"Maria","middleName":"Ludovica","lastName":"Macchia","suffix":""},{"id":372948100,"identity":"7e11c633-38a5-4dff-abfa-848f5960e08c","order_by":7,"name":"Massimo Bellanda","email":"","orcid":"https://orcid.org/0000-0002-8187-0264","institution":"Università degli Studi di Padova","correspondingAuthor":false,"prefix":"","firstName":"Massimo","middleName":"","lastName":"Bellanda","suffix":""},{"id":372948101,"identity":"2c4f16f7-8a98-4367-a5b3-03b8a12af001","order_by":8,"name":"Barbara Gatto","email":"","orcid":"https://orcid.org/0000-0001-9465-6913","institution":"University of Padova","correspondingAuthor":false,"prefix":"","firstName":"Barbara","middleName":"","lastName":"Gatto","suffix":""},{"id":372948102,"identity":"d891f378-d1a6-4412-b29a-cf54b03fc712","order_by":9,"name":"Giustina De Silvestro","email":"","orcid":"","institution":"University Hospital of Padova","correspondingAuthor":false,"prefix":"","firstName":"Giustina","middleName":"","lastName":"De Silvestro","suffix":""},{"id":372948103,"identity":"08b226b2-ec7c-41df-a73f-4d399d7ba4bf","order_by":10,"name":"Piero Marson","email":"","orcid":"","institution":"University Hospital of Padova","correspondingAuthor":false,"prefix":"","firstName":"Piero","middleName":"","lastName":"Marson","suffix":""},{"id":372948104,"identity":"4330a97f-8bd9-4441-b3f0-ad3b953cd3db","order_by":11,"name":"Paolo Simioni","email":"","orcid":"","institution":"University of Padua","correspondingAuthor":false,"prefix":"","firstName":"Paolo","middleName":"","lastName":"Simioni","suffix":""},{"id":372948105,"identity":"2fb00368-48bc-468b-bf7d-06a74b68aa03","order_by":12,"name":"Paola Picotti","email":"","orcid":"https://orcid.org/0000-0002-4109-3552","institution":"ETH Zurich, Department of Biology","correspondingAuthor":false,"prefix":"","firstName":"Paola","middleName":"","lastName":"Picotti","suffix":""}],"badges":[],"createdAt":"2024-08-22 15:45:37","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-4959212/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-4959212/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s42003-025-08570-2","type":"published","date":"2025-08-01T04:00:00+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":88148952,"identity":"2f7b3778-33c2-4c2e-b717-229837dd2984","added_by":"auto","created_at":"2025-08-02 07:10:32","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":2598633,"visible":true,"origin":"","legend":"","description":"","filename":"COMMSBIO246419T.docx.pdf","url":"https://assets-eu.researchsquare.com/files/rs-4959212/v1_covered_0be5f2e3-0b99-49ba-a6ae-14a7980fd3c0.pdf"},{"id":68875184,"identity":"2ff312eb-4a97-4742-9110-a22711f7303d","added_by":"auto","created_at":"2024-11-13 04:32:00","extension":"xlsx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":334167,"visible":true,"origin":"","legend":"\u003cp\u003eS1\u003c/p\u003e","description":"","filename":"SupplementaryTable1.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-4959212/v1/9676cc155691bbe2e1708525.xlsx"},{"id":68875183,"identity":"9441433e-3521-47ec-a882-4677f0923825","added_by":"auto","created_at":"2024-11-13 04:32:00","extension":"xlsx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":27692,"visible":true,"origin":"","legend":"\u003cp\u003eS2\u003c/p\u003e","description":"","filename":"SupplementaryTable2.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-4959212/v1/5469cb16e32e079604d362d5.xlsx"},{"id":68876291,"identity":"36da0696-0e9a-48d1-9ef6-437be5b54532","added_by":"auto","created_at":"2024-11-13 04:48:00","extension":"xlsx","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":261916,"visible":true,"origin":"","legend":"\u003cp\u003eS3\u003c/p\u003e","description":"","filename":"SupplementaryTable3.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-4959212/v1/3352ca9cd543bf9ad7b9046e.xlsx"},{"id":68876096,"identity":"fa07b119-2633-4ee4-8017-1d5a78f05e23","added_by":"auto","created_at":"2024-11-13 04:40:00","extension":"xlsx","order_by":4,"title":"","display":"","copyAsset":false,"role":"supplement","size":542059,"visible":true,"origin":"","legend":"S4","description":"","filename":"SupplementaryTable4.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-4959212/v1/63c2d38453d0350d2dfdf4af.xlsx"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"\u003cp\u003eThe Main protease (M\u003csup\u003epro\u003c/sup\u003e) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII\u003c/p\u003e","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"nature-portfolio","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"","title":"Nature Portfolio","twitterHandle":"","acdcEnabled":false,"dfaEnabled":false,"editorialSystem":"ejp","reportingPortfolio":"","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"COVID-19, SARS-CoV-2, Main Protease, thrombosis, proteolysis, proteomics","lastPublishedDoi":"10.21203/rs.3.rs-4959212/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-4959212/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"The connection between COVID-19 and coagulopathy has been clear since the early days of SARS-CoV-2 pandemic. Although available data indicate that systemic inflammation sustains a hypercoagulant state and increases thrombotic risk, the underlying molecular mechanisms of COVID-19 associated coagulopathy remain unclear. Here we show that SARS-CoV-2 main protease (Mpro) can play a direct role in the activation of the coagulation cascade. Adding Mpro to human plasma increased clotting probability by 2.5-fold. The results of enzymatic assays and degradomics analysis indicate that Mpro triggers plasma clotting by proteolytically activating coagulation factor zymogens VII and XII at their physiological activation sites, involving Arg-Ile/Val bonds, where FVII and FXII are strategically positioned at the beginning of the extrinsic or intrinsic pathways of blood coagulation. Even though the observed cleavage sites are not compatible with the known substrate specificity of the protease, involving Gln-X bonds, the results of High Throughput Protease Screen assay unveil an extended, time-dependent, secondary specificity of Mpro for Arg-X bonds, which was further confirmed by enzymatic assays with synthetic peptide substrates containing Arg at P1 position. Overall, integrating biochemical, proteomics and structural biology experiments, we unveil a novel, additional mechanism linking SARS-CoV-2 infection to thrombotic complications in COVID-19.","manuscriptTitle":"The Main protease (Mpro) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-11-13 04:31:55","doi":"10.21203/rs.3.rs-4959212/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"communications-biology","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"commsbio","sideBox":"Learn more about [Communications Biology](http://www.nature.com/commsbio/)","snPcode":"","submissionUrl":"","title":"Communications Biology","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Communications Series","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"67724318-1ad9-4ce5-ae94-7cb4b21cbeb3","owner":[],"postedDate":"November 13th, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":40185175,"name":"Biological sciences/Biochemistry/Proteases"},{"id":40185176,"name":"Biological sciences/Microbiology/Virology/SARS-CoV-2"}],"tags":[],"updatedAt":"2025-08-02T07:10:24+00:00","versionOfRecord":{"articleIdentity":"rs-4959212","link":"https://doi.org/10.1038/s42003-025-08570-2","journal":{"identity":"communications-biology","isVorOnly":false,"title":"Communications Biology"},"publishedOn":"2025-08-01 04:00:00","publishedOnDateReadable":"August 1st, 2025"},"versionCreatedAt":"2024-11-13 04:31:55","video":"","vorDoi":"10.1038/s42003-025-08570-2","vorDoiUrl":"https://doi.org/10.1038/s42003-025-08570-2","workflowStages":[]},"version":"v1","identity":"rs-4959212","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-4959212","identity":"rs-4959212","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-4.0